Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Oct 10, 2014; 5(4): 677-692
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.677
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.677
Figure 4 Comparison of selective and non-selective cyclooxygenase-2 inhibitors in cancer prevention.
Bars represent 95%CI of each estimate[101].
- Citation: Harris RE, Casto BC, Harris ZM. Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol 2014; 5(4): 677-692
- URL: https://www.wjgnet.com/2218-4333/full/v5/i4/677.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i4.677